medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 5

<< Back Next >>

Gac Med Mex 2016; 152 (5)

El intervencionismo percutáneo en la corrección de defectos cardíacos congénitos (DCC): experiencia en una UMAE

Campos-García V, Ordóñez TG, Monjaraz-Rodríguez S
Full text How to cite this article

Language: Spanish
References: 20
Page: 667-673
PDF size: 100.52 Kb.


Key words:

Congenital heart defects, Congenital heart disease, Percutaneous intervention.

ABSTRACT

Introduction: Congenital heart defects are common in infants and adults, affecting quality of life if not corrected. Unlike open surgery, percutaneous intervention allows correction with a high success rate and speedy recovery. In Mexico, there are not enough studies to describe their efficacy and safety. Methods: A cohort study was conducted in the Hospital “Manuel Avila Camacho”, in Puebla, Mexico, including 149 patients with congenital heart defects repaired by percutaneous intervention, recording data from clinical records. The following were documented: post-guided fluoroscopy, hemodynamic changes, cardiac catheterization drilling anatomical changes, and complications six months later such as infection or bleeding at the puncture site, device migration, endocarditis, or death. SPSS was used, using descriptive and inferential statistics. Results: The patients’ congenital heart defects treated were ductus arteriosus, atrial septal defect, and aortic coarctation, with ductus coroarteriosus being recorded as the most frequent congenital heart defect. Primary angioplasties were performed in 75% and stenting in the rest. Anatomical corrections of congenital defects were successful in 96.4% of patients (p ‹ 0.01), with minimal adverse effects (p ‹ 0.01). Conclusions: We conclude that our hospital has good efficacy and safety in percutaneous intervention, comparable to published reports. monjarazsa@hotmail.com


REFERENCES

  1. Casaldáliga J, Oliver J, Subirana MT. Cardiopatías congénitas en la edad adulta ¿Ficción o realidad? Introducción. Rev Esp Cardiol. 2009;9 (Suppl):1E-2E.

  2. Mendieta GG, Santiago E, Mendieta H, Dorantes R, Ortíz G, Otero G. Incidencia de las cardiopatías congénitas y los factores asociados a la letalidad en niños nacidos en dos hospitales del Estado de México. Gac Med Mex. 2013;149:617-23.

  3. Galván LL, García E, Valdespino A, Camacho R. Cardiopatías congenitas en el adulto diagnosticadas por ecocardiografía transtorácica. Rev Mex Cardiol. 2009;20:12-7.

  4. Arzamendi D, Miró J. Intervencionismo en las cardiopatías congéntas del adulto. Rev Esp Cardiol. 2012;65:690-9.

  5. Zabal C. El cateterismo intervencionista en las cardiopatías congénitas. Arch Cardiol Mex. 2001;71:S188-91.

  6. Attie F. Cardiopatías congénitas en el adulto. Arch Cardiol Mex. 2001;71:S10-6.

  7. Riera C. Actualidades en el tratamiento quirúrgico de las cardiopatías congénitas. Rev Mex Ped. 2010;77:214-23.

  8. Bermúdez R, Abelleira C, Sánchez I. Cardiopatías congénitas del adulto: procedimientos terapeuticos percutáneos. Rev Esp Cardiol. 2009; 9(Suppl):75E-97E.

  9. Akagi T. Catheter intervention for adult patients with congenital heart disease. J Cardiol. 2012;60:151-9.

  10. Howaida G, Bratincsak A, Foerster S, et al. Safety of percutaneous patent ductus arteriosus closure: an un selected multicenter population experience. Am Heart J. 2013;10:113-424.

  11. Spies C, Cao QL, Higazi ZM. Transcatheter closure of congenital and acquired. Europ Her J Suppl. 2010;10(Suppl):E24-34.

  12. Holzer R, Gauvreau K, Kreutzer J, Leahy R, Murphy J, Lock J. Ballon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural charasteristic: result of a multiinstitutional registry. Circ Cardiovasc Interv. 2011;4:287-96.

  13. Bergersen L, Gauvreau K, Foerster S, Marshall A, McElhinney D, Beekman R. Catheterization for congenital heart disease adjustment for risk method (CHARM). JACC Cardiovasc Interv. 2011;4:1037-46.

  14. Arzamendi D, Miró J. Intervencionismo en las cardiopatías congénitas del adulto. Rev Esp Cardiol. 2012;65:690-9.

  15. Kotowycz M, Therrien J, Ionescu R, et al. Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv. 2013;6:497-503.

  16. Yang J, Yang L, Yu S, Liu J, Zuo J, Chen W. Transcatheter versus surgical closure of perimembranous ventricular septal defects in Children: A Randomized Controled Trial. Jour Amer Coll Cardiol. 2014;63:1159-68.

  17. Tzifa A, Papagiannis J, Qureshi S. Iatrogenic Aortopulmonary Windows After Balloon Dilation of Left Pulmonary Artery Stenosis Following Arterial Switch Operation. J Inv Cardiol. 2013;25:E188-90.

  18. Ammar RI. Balloon Angioplasty for Native Aortic Coarctation in Children and Infants Younger Than 12 Months: Immediate and Medium-Term Follow-Up. J Inv Cardiol. 2012;24:662-6.

  19. Bhatt A, Foster E, Kuehl K, et al. Congenital Heart Disease in the Older Adult A Scientific Statement From the American Heart Association. Circulation. 2015;131:1884-931.

  20. Baumgartner H, Bonhoeffer P, De Groot N, et al. Guía de práctica clínica de la ESC para el manejo de cardiopatias congénitas en el adulto (nueva versión 2010). Rev Esp Cardiol. 2010;63:1484.e1-59.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2016;152